Trigger Finger Aug 2020 v5
Trigger Finger Aug 2020 v5
Trigger Finger Aug 2020 v5
Definition
Trigger finger (stenosing tenosynovitis) is an acquired condition in which the sheath for the flexor
tendon of a finger or the thumb thickens and narrows. This causes the flexor tendon to not glide
freely through it, leading to pain, intermittent snapping (“triggering”) or actual locking (in flexion or
extension) of the affected digit (finger).
Policy
Referral for treatment should be through the MSK service/pathway.
It is the responsibility of referring and treating clinicians to ensure compliance with this
policy. Referral proforma should be attached to the patient notes to aid the clinical audit
process and provide evidence of compliance with the policy. For patients not meeting the
policy criteria, clinicians can apply for funding to the Exceptional Cases Panel by
completing the exceptional funding section of the referral proforma.
The CCG will ONLY fund surgery for trigger finger (preferably percutaneous) according to the
Surgical Threshold Policy
following criteria:
The patient has moderate symptoms as defined below which have not improved following
conservative treatment, eg encouragement to regularly move the finger, rest from aggravating
activities, splinting, NSAIDs, and at least one corticosteroid injection (unless contraindicated).
OR
The patient has severe symptoms as defined below that cannot be corrected with any other
method.
Classification for Severity of Trigger Finger:
Mild (pre-triggering): History of pain and catching or “click”.
or tender A1 pulley (tendon); but fully mobile finger.
Moderate: Triggering with difficulty actively extending finger or need for passive
finger extension.
or loss of complete active flexion.
Severe: Fixed contracture.
Note:
Patients who smoke should be advised to attempt to stop smoking and referred to stop-smoking
services – see stop smoking policy1, 2.
We acknowledge there may be a difference in response of some patients with diabetes to
conservative treatments3 but suggest these are offered in the context of the shared decision-
making process.
Rationale and Evidence
• Spontaneous recovery has been reported in up to 29% of cases4.
• Steroid injections are advised before surgery due to ease of use within the outpatient setting
and low morbidity rate or complications5.
• Initial treatment of trigger finger is conservative. Steroid injections are efficacious and should
be attempted before surgical intervention6, 7.
_____________
Page 1 of 2
Rational and Evidence cont’d
• Trigger finger cure rate has been shown in patients who were treated with corticosteroid
injections (57%) and this improved with two injections (86%) whilst remission was achieved in
all cases for surgical methods at 6 months8.
• Some evidence suggests that patients with diabetes respond less well to corticosteroid
injection9
Estimated number of
people affected
The overall lifetime incidence of trigger finger is 2 in 1004. It occurs in childhood and adulthood
(most frequently in the fifth to sixth decades) and is more common in women5. Diabetes,
rheumatoid arthritis, thyroid disease, kidney disease and other rarer disorders are risk factors for
trigger finger
References
1. C Furlong. Preoperative Smoking Cessation: A Model to Estimate Potential Short Term Health Gain
and Reductions in Length of Stay. A report by London Health Observatory. September 2005.
2. S Hajioff, M Bhatti. Pre-operative smoking cessation therapy in NCL. A case of short-term gain for
long-term gain?
3. NHS England Medical directorate and Strategy and Innovation directorate, 2018, Evidence-Based
Interventions: Guidance for Clinical Commissioning Groups, NHS England, viewed 16th January 2020,
<https://www.england.nhs.uk/wp-content/uploads/2018/11/ebi-statutory-guidance-v2.pdf>
4. Schofield C B, Citron N D. (1993). The natural history of adult trigger thumb. J Hand Surg [Br]. 1993
Apr;18(2):247-8.
5. Wolfe S W. Tenosynovitis, 2137-2158, Chapter 60. Green’s Operative Hand Surgery Ed’s Green DP,
Hotchkiss RN, Pederson W C, Wolfe S W . Elsevier, Churchill Livingstone, 2005.
6. Sheryl B, Fleisch, B S, et al. (2007). Corticosteroid Injections in the Treatment of Trigger Finger: A
Level I and II Systematic Review. J Am Acad Orthop Surg, Vol 15, No 3, March 2007, 166-171.
7. Kerrigan C L, Stanwix M G. (2009). Using evidence to minimize the cost of trigger finger care. J Hand
Surg Am. 2009 Jul-Aug;34(6):997-1005.
8. Sato E S, Gomes Dos Santos J B, et al. (2011). Treatment of trigger finger: randomized clinical trial
comparing the methods of corticosteroid injection, percutaneous release and open surgery.
Rheumatology (Oxford). 2012 Jan;51(1):93-9
9. Chang C – J, et al (2018). A Meta-analyisis of Corticosteroid Injection for Trigger Digits among
Patients with Diabetes. Orthopedics, Doyle J R. (1988). Anatomy of the finger flexor tendon sheath
and pulley system. J. Hand Surg. Vol 13-A. 1988. p 473.
10. Doyle J R (1988). Anatomy of the finger flexor tendon sheath and pulley system. J Hand Surg. Vol
13. 1988. p473
11. Blacks Medical Dictionary. 42nd Edition. A & C Black. London 2010.
Glossary10, 11
Flexor tendon: Flexor tendons are strong smooth cords that connect the muscles of the forearm to
the bones in the fingers and thumb. There are two to each finger and one for the
thumb.
Stenosing: An abnormal narrowing or contraction of a duct or canal.